Shaping of NK cell subsets by aging

Current Opinion in Immunology

Volumn 29, Issue 1, 2014, Pages 56-61

  Solana, Rafael ^a   Campos, Carmen ^a   Pera, Alejandra ^a   Tarazona, Raquel ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; FC RECEPTOR;

AGING; CELL EXPANSION; CELL METABOLISM; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; HUMAN; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; ANIMAL; CELL SHAPE; CYTOLOGY; HOMEOSTASIS; IMMUNOLOGY;

AGING; ANIMALS; ANTIGENS, CD56; CELL SHAPE; HOMEOSTASIS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IGG;

EID: 84899686409     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.04.002     Document Type: Review

References (56)

1. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N., Mebius R.E., et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013, 13:145-149.
2. Luetke-Eversloh M., Killig M., Romagnani C. Signatures of human NK cell development and terminal differentiation. Front Immunol 2013, 4:499.
3. Sun J.C., Lanier L.L. NK cell development, homeostasis and function: parallels with CD8 T cells. Nat Rev Immunol 2011, 11:645-657.
4. Long E.O., Kim H.S., Liu D., Peterson M.E., Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013, 31:227-258.
5. Campos C., Pera A., Sanchez-Correa B., Alonso C., Lopez-Fernandez I., Morgado S., Tarazona R., Solana R. Effect of age and CMV on NK cell subpopulations. Exp Gerontol 2014, 54:130-137.
6. Romagnani C., Juelke K., Falco M., Morandi B., D'Agostino A., Costa R., Ratto G., Forte G., Carrega P., Lui G., et al. CD56brightCD16- killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007, 178:4947-4955.
7. Ouyang Q., Baerlocher G., Vulto I., Lansdorp P.M. Telomere length in human natural killer cell subsets. Ann N Y Acad Sci 2007, 1106:240-252.
8. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 2006, 24:257-286.
9. Huntington N.D., Vosshenrich C.A., Di Santo J.P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007, 7:703-714.
10. Poli A., Michel T., Theresine M., Andres E., Hentges F., Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009, 126:458-465.
11. Mace E.M., Hsu A.P., Monaco-Shawver L., Makedonas G., Rosen J.B., Dropulic L., Cohen J.I., Frenkel E.P., Bagwell J.C., Sullivan J.L., et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood 2013, 121:2669-2677.
12. Dulphy N., Haas P., Busson M., Belhadj S., Peffault de L.R., Robin M., Carmagnat M., Loiseau P., Tamouza R., Scieux C., et al. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol 2008, 181:2227-2237.
13. Borrego F., Alonso M.C., Galiani M.D., Carracedo J., Ramirez R., Ostos B., Pena J., Solana R. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 1999, 34:253-265.
14. Chidrawar S.M., Khan N., Chan Y.L., Nayak L., Moss P.A. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun Ageing 2006, 3:10.
15. Wang J., Geiger H., Rudolph K.L. Immunoaging induced by hematopoietic stem cell aging. Curr Opin Immunol 2011, 23:532-536.
16. Zhang Y., Wallace D.L., de Lara C.M., Ghattas H., Asquith B., Worth A., Griffin G.E., Taylor G.P., Tough D.F., Beverley P.C., et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 2007, 121:258-265.
17. Mariani E., Meneghetti A., Neri S., Ravaglia G., Forti P., Cattini L., Facchini A. Chemokine production by natural killer cells from nonagenarians. Eur J Immunol 2002, 32:1524-1529.
18. Hayhoe R.P., Henson S.M., Akbar A.N., Palmer D.B. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum Immunol 2010, 71:676-681.
19. Solana R., Mariani E. NK and NK/T cells in human senescence. Vaccine 2000, 18:1613-1620.
20. Kaszubowska L., Ttlaff-Pokora A., Hak L., Szarynska M., Ryba M., Mysliwska J., Mysliwski A. Successful ageing of nonagenarians is related to the sensitivity of NK cells to activation. J Physiol Pharmacol 2008, 59:187-199.
21. Solana R., Tarazona R., Gayoso I., Lesur O., Dupuis G., Fulop T. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 2012, 24:331-341.
22. Gayoso I., Sanchez-Correa B., Campos C., Alonso C., Pera A., Casado J.G., Morgado S., Tarazona R., Solana R. Immunosenescence of human natural killer cells. J Innate Immun 2011, 3:337-343.
23. Hazeldine J., Lord J.M. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev 2013, 12:1069-1078.
24. Rea I.M., Maxwell L.D., McNerlan S.E., Alexander H.D., Curran M.D., Middleton D., Ross O.A. Killer Immunoglobulin-like Receptors (KIR) haplogroups A and B track with Natural Killer Cells and Cytokine Profile in Aged Subjects: Observations from Octo/Nonagenarians in the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST). Immun Ageing 2013, 10:35.
25. Lutz C.T., Quinn L.S. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany, NY) 2012, 4:535-546.
26. Remarque E., Pawelec G. T cell immunosenescence and its clinical relevance in man. Rev Clin Gerontol 1998, 8:5-14.
27. Ogata K., An E., Shioi Y., Nakamura K., Luo S., Yokose N., Minami S., Dan K. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 2001, 124:392-397.
28. Le Garff-Tavernier M., Beziat V., Decocq J., Siguret V., Gandjbakhch F., Pautas E., Debre P., Merle-Beral H., Vieillard V. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 2010, 9:527-535.
29. Almeida-Oliveira A., Smith-Carvalho M., Porto L.C., Cardoso-Oliveira J., Ribeiro A.S., Falcao R.R., Abdelhay E., Bouzas L.F., Thuler L.C., Ornellas M.H., et al. Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol 2011, 72:319-329.
30. Sanchez-Correa B., Gayoso I., Bergua J.M., Casado J.G., Morgado S., Solana R., Tarazona R. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Immunol Cell Biol 2012, 90:109-115.
31. Lutz C.T., Moore M.B., Bradley S., Shelton B.J., Lutgendorf S.K. Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev 2005, 126:722-731.
32. Jamieson A.M., Isnard P., Dorfman J.R., Coles M.C., Raulet D.H. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol 2004, 172:864-870.
33. Cooper M.A., Elliott J.M., Keyel P.A., Yang L., Carrero J.A., Yokoyama W.M. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 2009, 106:1915-1919.
34. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
35. Sun J.C., Beilke J.N., Bezman N.A., Lanier L.L. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J Exp Med 2011, 208:357-368.
36. Sun J.C., Madera S., Bezman N.A., Beilke J.N., Kaplan M.H., Lanier L.L. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med 2012, 209:947-954.
37. Lopez-Verges S., Milush J.M., Schwartz B.S., Pando M.J., Jarjoura J., York V.A., Houchins J.P., Miller S., Kang S.M., Norris P.J., et al. Expansion of a unique CD57NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A 2011, 108:14725-14732.
38. Muntasell A., Vilches C., Angulo A., Lopez-Botet M. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur J Immunol 2013, 43:1133-1141.
39. Noyola D.E., Fortuny C., Muntasell A., Noguera-Julian A., Munoz-Almagro C., Alarcon A., Juncosa T., Moraru M., Vilches C., Lopez-Botet M. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur J Immunol 2012, 42:3256-3266.
40. Monsivais-Urenda A., Noyola-Cherpitel D., Hernandez-Salinas A., Garcia-Sepulveda C., Romo N., Baranda L., Lopez-Botet M., Gonzalez-Amaro R. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 2010, 40:1418-1427.
41. Guma M., Budt M., Saez A., Brckalo T., Hengel H., Angulo A., Lopez-Botet M. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-3631.
42. Foley B., Cooley S., Verneris M.R., Pitt M., Curtsinger J., Luo X., Lopez-Verges S., Lanier L.L., Weisdorf D., Miller J.S. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012, 119:2665-2674.
43. Bjorkstrom N.K., Lindgren T., Stoltz M., Fauriat C., Braun M., Evander M., Michaelsson J., Malmberg K.J., Klingstrom J., Ahlm C., et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011, 208:13-21.
44. Petitdemange C., Becquart P., Wauquier N., Beziat V., Debre P., Leroy E.M., Vieillard V. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog 2011, 7:e1002268.
45. Beziat V., Dalgard O., Asselah T., Halfon P., Bedossa P., Boudifa A., Hervier B., Theodorou I., Martinot M., Debre P., et al. CMV drives clonal expansion of NKG2C(+) NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 2012, 42:447-457.
46. Cannon M.J., Schmid D.S., Hyde T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010, 20:202-213.
47. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A. Human immunosenescence: is it infectious?. Immunol Rev 2005, 205:257-268.
48. Pawelec G., McElhaney J.E., Aiello A.E., Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol 2012, 24:507-511.
49. Nielsen C.M., White M.J., Goodier M.R., Riley E.M. Functional significance of CD57 expression on human NK cells and relevance to disease. Front Immunol 2013, 4:422.
50. Mariani E., Meneghetti A., Formentini I., Neri S., Cattini L., Ravaglia G., Forti P., Facchini A. Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing. Exp Gerontol 2003, 38:653-659.
51. Bjorkstrom N.K., Ljunggren H.G., Sandberg J.K. CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol 2010, 31:401-406.
52. Tarazona R., Casado J.G., DelaRosa O., Torre-Cisneros J., Villanueva J.L., Sanchez B., Galiani M.D., Gonzalez R., Solana R., Pena J. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol 2002, 22:176-183.
53. Mavilio D., Lombardo G., Benjamin J., Kim D., Follman D., Marcenaro E., O'Shea M.A., Kinter A., Kovacs C., Moretta A., et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 2005, 102:2886-2891.
54. Gonzalez V.D., Falconer K., Bjorkstrom N.K., Blom K.G., Weiland O., Ljunggren H.G., Alaeus A., Sandberg J.K. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. J Immunol 2009, 183:6612-6618.
55. Milush J.M., Lopez-Verges S., York V.A., Deeks S.G., Martin J.N., Hecht F.M., Lanier L.L., Nixon D.F. CD56negCD16+ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology 2013, 10:158.
56. Della C.M., Falco M., Podesta M., Locatelli F., Moretta L., Frassoni F., Moretta A. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?. Blood 2012, 119:399-410.